Drug poisonings following bariatric surgery: Case series report
Abstract
Bariatric surgery alters gastrointestinal anatomy and physiology, which likely impacts upon oral medication absorption. Drug- and alcohol-related deaths in this population are being increasingly reported; however, toxicological detail is lacking. Using data reported to the National Programme on Substance Use Mortality, we identified 18 deaths in people who had previously undergone bariatric surgery. Opioids were detected in almost all cases and were frequently implicated in causing death. Multiple medications were detected at post-mortem in every case and often included medications that the deceased was not actively prescribed. Mental health conditions and chronic pain were commonly listed comorbidities and one-third of deaths were deemed suicide. Illicit drug and alcohol use was rare, highlighting a distinct vulnerability to prescription medication harms. Our findings emphasize a need to understand how bariatric surgery alters pharmacokinetics and for integrated, multidisciplinary aftercare, therapeutic drug monitoring and tailored education of safe medication use in bariatric surgery patients.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 18 participants or records.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.